RN7SL592P

Across TCGA pan-cancer cohorts, RN7SL592P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL592P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RN7SL592P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL592P expression acts as an unfavorable survival marker, although some lineages such as LIHC and UCS show a favorable association.

LIHC, COAD, and KIRP are the cancer types where RN7SL592P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	III,IV	0.793	0.119	.005	45	view →
COAD	OS	Tertile	All	0.566	0.849	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.131	0.712	.006	36	view →
UCS	OS	Tertile	II,III,IV	1.000	0.336	.024	30	view →
MESO	DFS	Quartile	III,IV	0.204	0.414	.002	27	view →
BLCA	OS	Tertile	IV	0.063	0.576	<.001	18	view →
READ	DFS	Tertile	III,IV	0.236	0.662	.007	12	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
LUAD	DFS	Quartile	IV	0.896	0.384	.045	6	view →
KICH	DFS	Quartile	II,III,IV	0.563	0.896	.044	3	view →
SKCM	OS	Tertile	III,IV	0.240	0.426	.023	3	view →
HNSC	DFS	Tertile	II,III,IV	0.789	0.675	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RN7SL592P–LIHC (DFS)

Open the LIHC breakdown →